Prudential Financial’s 10x Genomics TXG Stock Holding History

Prudential Financial’s Portfolio TXG Stock Details TXG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.34M	Buy	+63,170	New	+$1.26M	﹤0.01%	1487
2025 Q4	–	Sell	-35,700	Closed	-$417K	–	2444
2025 Q3	$417K	Buy	35,700 +21,775	+156%	+$284K	﹤0.01%	2008
2025 Q2	$161K	Buy	+13,925	New	+$127K	﹤0.01%	2242
2022 Q1	–	Sell	-12,850	Closed	-$1.95M	–	2697
2021 Q4	$1.95M	Sell	12,850 -24	-0.2%	-$3.68K	﹤0.01%	1555
2021 Q3	$1.91M	Sell	12,874 -6,304	-33%	-$1.08M	﹤0.01%	1487
2021 Q2	$3.76M	Buy	19,178 +550	+3%	+$99.5K	0.01%	1156
2021 Q1	$3.37M	Sell	18,628 -27	-0.1%	-$4.66K	0.01%	1203
2020 Q4	$2.64M	Buy	18,655 +4,311	+30%	+$626K	﹤0.01%	1296
2020 Q3	$1.79M	Sell	14,344 -6,586	-31%	-$691K	﹤0.01%	1369
2020 Q2	$1.87M	Buy	+20,930	New	+$1.63M	﹤0.01%	1368

Other funds holding TXG

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

QCM

Quantinno Capital Management New York $59.9B AUM 28.07% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Prudential Financial's TXG Position: Q1 2026 in Review

Prudential Financial opened a new position in 10x Genomics (TXG) in Q1 2026: 63,170 shares worth $1.34M. The stake represents ﹤0.01% of the portfolio and ranks #1487 among its holdings. This is a return to the name: Prudential Financial previously reported a position in TXG as recently as Q3 2025.

Prudential Financial first reported a position in TXG in Q2 2020 and has held it in 10 quarters since. The position peaked at $3.76M in Q2 2021. 329 funds tracked by Wall St. Rank hold TXG as of Q1 2026.

Prudential Financial held 63,170 shares of 10x Genomics worth $1.34M as of Q1 2026.
10x Genomics was a new Prudential Financial position in Q1 2026.
10x Genomics made up ﹤0.01% of Prudential Financial's portfolio in Q1 2026, its #1487 holding.
Prudential Financial first reported a position in 10x Genomics in Q2 2020 and has held it in 10 quarters since.
Prudential Financial's 10x Genomics position peaked at $3.76M in Q2 2021.
329 funds tracked by Wall St. Rank held 10x Genomics as of Q1 2026.

Based on Prudential Financial's 13F filing for Q1 2026, filed 13 May 2026.